Letter: Hypoglycemia Assessed by Continuous Glucose Monitoring: A Proposal to Define the End of a Hypoglycemic Event More Precisely

FDA. Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products Guidance for Industry, 2023.

Battelino T , Alexander CM , Amiel SA , et al. Continuous glucose monitoring and metrics for clinical trials: An international consensus statement. Lancet Diabetes Endocrinol, 2023; 11(1):42–57; doi: 10.1016/S2213-8587(22)00319-9